Effects of rare CYP2C9 alleles on stable warfarin doses in Chinese Han patients with atrial fibrillation

被引:6
|
作者
Wang, Dongxu [1 ]
Dai, Da-Peng [2 ]
Wu, Hualan [1 ]
Chong, Jia [1 ]
Lu, You [1 ]
Yin, Ruoyun [1 ]
Zhao, Xinlong [1 ]
Zhao, Anxu [1 ]
Yang, Jiefu [1 ]
Chen, Hao [1 ]
机构
[1] Beijing Hosp, Cardiovasc Dept, Natl Ctr Gerontol, Beijing 100730, Peoples R China
[2] Beijing Hosp, Natl Ctr Gerontol, Key Lab Geriatr, Beijing 100730, Peoples R China
基金
美国国家科学基金会;
关键词
atrial fibrillation; gene polymorphism; warfarin-dosing algorithm; warfarin; GENETIC-VARIANTS; IN-VITRO; FUNCTIONAL-CHARACTERIZATION; CYP2C9-ASTERISK-13; ALLELE; GENOTYPE; VKORC1; IDENTIFICATION; REQUIREMENT; PHARMACOKINETICS; ANTICOAGULATION;
D O I
10.2217/pgs-2020-0051
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim:Gene polymorphisms are critical in warfarin dosing variation. Here, the role of rareCYP2C9alleles on warfarin doses in Chinese Han patients was investigated.Methods:A retrospective study recruited 681 warfarin treated atrial fibrillation patients. The genetic and clinical data were collected. Dose-related variables were selected by univariate analyses and the warfarin-dosing algorithm was derived by multivariate regression analysis.Results:Three rareCYP2C9alleles (CYP2C9*13, *16 and *60) were associated with lower stable doses. Inclusion of the rareCYP2C9alleles in the prediction model added an extra 3.7% warfarin dose predictive power.Conclusion:CYP2C9*13, *16 and *60 was associated with lower stable warfarin doses in Chinese patients. The algorithm including rareCYP2C9alleles tends to more accurately predict stable warfarin doses.
引用
收藏
页码:1021 / 1031
页数:11
相关论文
共 50 条
  • [31] Effects of CYP2C9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam
    Bae, Jung-Woo
    Choi, Chang-Ik
    Jang, Choon-Gon
    Lee, Seok-Yong
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (04) : 550 - 555
  • [32] Impact of CYP2C9, VKORC1, ApoE and ABCB1 polymorphisms on stable warfarin dose requirements in elderly Chinese patients
    Li, Wenyan
    Zhao, Ping
    Chen, Liwen
    Lai, Xiaoyin
    Shi, Guohua
    Li, Longxuan
    Dong, Jing
    PHARMACOGENOMICS, 2020, 21 (02) : 101 - 110
  • [33] Phenytoin Metabolic Ratio, a Marker of CYP2C9 Activity, is Superior to the CYP2C9 Genotype as a Predictor of (S)-Warfarin Clearance
    Shaul, Chanan
    Blotnick, Simcha
    Adar, Liat
    Muszkat, Mordechai
    Bialer, Meir
    Caraco, Yoseph
    CLINICAL PHARMACOKINETICS, 2022, 61 (08) : 1187 - 1198
  • [34] Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients
    Ye, Changqing
    Jin, Haiqiang
    Zhang, Rui
    Sun, Yongan
    Wang, Zhaoxia
    Sun, Weiping
    Sun, Wei
    Peng, Qing
    Liu, Ran
    Huang, Yining
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2014, 42 (01) : 67 - 76
  • [35] The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on Optimal Warfarin Doses After Heart Valve Replacement
    Tatarunas, Vacis
    Lesauskaite, Vaiva
    Veikutiene, Audrone
    Jakuska, Povilas
    Benetis, Rimantas
    MEDICINA-LITHUANIA, 2011, 47 (01): : 25 - 30
  • [37] Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement
    Quinn, Alison L. H.
    Liko, Ina
    Lee, James C.
    PHARMACOGENOMICS, 2017, 18 (11) : 1051 - 1057
  • [38] Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population
    Zhao, Fang-Ling
    Zhang, Qing
    Wang, Shuang-Hu
    Hong, Yun
    Zhou, Shan
    Zhou, Quan
    Geng, Pei-Wu
    Luo, Qing-Feng
    Yang, Jie-Fu
    Chen, Hao
    Cai, Jian-Ping
    Dai, Da-Peng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [39] In vitro metabolism of phenytoin in 36 CYP2C9 variants found in the Chinese population
    Chen, Lian-Guo
    Wang, Zhe
    Zhu, Yuan
    Xiong, Jian-Hua
    Sun, Li-Rong
    Dai, Da-Peng
    Cai, Jian-Ping
    Hu, Guo-Xin
    CHEMICO-BIOLOGICAL INTERACTIONS, 2016, 253 : 93 - 99
  • [40] In Vitro and In Vivo Characterization of 13 CYP2C9 Allelic Variants Found in Chinese Han Population
    Hu, Guo-Xin
    Pan, Pei-Pei
    Wang, Zeng-Shou
    Yang, Li-Ping
    Dai, Da-Peng
    Wang, Shuang-Hu
    Zhu, Guang-Hui
    Qiu, Xiang-Jun
    Xu, Tao
    Luo, Jun
    Lian, Qing-Quan
    Ge, Ren-Shan
    Cai, Jian-Ping
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (04) : 561 - 569